| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6113487 | Critical Reviews in Oncology/Hematology | 2016 | 37 Pages |
Abstract
This review provides a summary of the latest evidence providing insight into the management of early and advanced HER2-positive breast cancer and delineates future perspectives of study and treatment for these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Fabio Puglisi, Caterina Fontanella, Vito Amoroso, Giulia Valeria Bianchi, Giancarlo Bisagni, Cristina Falci, Andrea Fontana, Daniele Generali, Lorenzo Gianni, Antonio Grassadonia, Luca Moscetti, Ilaria Portarena, Emanuela Rossi, Paolo Marchetti,